More info. Accept DE EN Siegfried is a trendsetter in the CDMO industry, driven by very loyal people. Latest News November 17, 2021 Siegfried included in the Dow Jones Sustainability Index Europe Siegfried is proud to announce that it has been selected for the first time as a member of the Dow Jones Sustainability Index (DJSI) Europe, in recognition of its commitment to and implemen-tation ... show all news » Upcoming Events Investor Relations Publication of 2021 Financial Results The financial results for the year 2021 will be published on 23 February 2022. show all events » Share Price Expect more with Siegfried as your preferred integrated partner: Bringing together our long-standing pharma and chemical heritage, we offer benefits to our customers with more synergy, expertise and value. more » Come and find out more about a company with a strong tradition of innovation where you really can “expect more”. About us Come and find out more about a company with a strong tradition of innovation where you really can “expect more”. Working at Siegfried Explore more about how our broad range of customer development services, drug substance & drug product manufacturing and packaging capabilities together with our existing product portfolio may help you achieve greater value. Drug Substance API Intermediates Exclusive Synthesis Portfolio (API, Controlled Substances) Drug Products Oral Solids Steriles Biologics Contract- or Co-Development and Manufacturing Licensing Can`t find the information you're looking for? Contact us Siegfried AG Untere Bruehlstrasse 4 4800 Zofingen Switzerland Phone: +41 62 746 11 11 Mail 2020 © Siegfried Holding AG Imprint / Terms and Conditions / Privacy notice